The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles

Derived from pooled blood donations, polyvalent immunoglobulins are used for post-exposure prophylaxis as one aspect of the public health management of hepatitis A, rubella and measles. This review summarizes the safety profile of these blood products and the current recommendations for their use fo...

Descripción completa

Detalles Bibliográficos
Autor principal: Young, Megan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773380/
https://www.ncbi.nlm.nih.gov/pubmed/31116633
http://dx.doi.org/10.1080/21645515.2019.1621148
_version_ 1783455891982385152
author Young, Megan K.
author_facet Young, Megan K.
author_sort Young, Megan K.
collection PubMed
description Derived from pooled blood donations, polyvalent immunoglobulins are used for post-exposure prophylaxis as one aspect of the public health management of hepatitis A, rubella and measles. This review summarizes the safety profile of these blood products and the current recommendations for their use for the prevention of hepatitis A, rubella and measles among people who have been exposed to these diseases. The current recommendations are drawn from the most recent publicly available national guidelines of the United States, Australia, New Zealand, Canada and the United Kingdom as accessed in February 2019.
format Online
Article
Text
id pubmed-6773380
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-67733802019-10-11 The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles Young, Megan K. Hum Vaccin Immunother Review Derived from pooled blood donations, polyvalent immunoglobulins are used for post-exposure prophylaxis as one aspect of the public health management of hepatitis A, rubella and measles. This review summarizes the safety profile of these blood products and the current recommendations for their use for the prevention of hepatitis A, rubella and measles among people who have been exposed to these diseases. The current recommendations are drawn from the most recent publicly available national guidelines of the United States, Australia, New Zealand, Canada and the United Kingdom as accessed in February 2019. Taylor & Francis 2019-06-19 /pmc/articles/PMC6773380/ /pubmed/31116633 http://dx.doi.org/10.1080/21645515.2019.1621148 Text en © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Review
Young, Megan K.
The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
title The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
title_full The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
title_fullStr The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
title_full_unstemmed The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
title_short The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
title_sort indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis a, rubella and measles
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773380/
https://www.ncbi.nlm.nih.gov/pubmed/31116633
http://dx.doi.org/10.1080/21645515.2019.1621148
work_keys_str_mv AT youngmegank theindicationsandsafetyofpolyvalentimmunoglobulinforpostexposureprophylaxisofhepatitisarubellaandmeasles
AT youngmegank indicationsandsafetyofpolyvalentimmunoglobulinforpostexposureprophylaxisofhepatitisarubellaandmeasles

Ejemplares similares